AzTrials
AzTrials

Preventive PracticePrevmedNCT07829601

Prevention Habits of Medical Doctors

An observational study of Preventive Practice, run by University Hospital, Clermont-Ferrand at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable. The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these… Read more about this study

Who is it for?
Any age
Conditions the study is for
Preventive Practice
What is being tested?
PREVMED questionnaire
How many people
500 participants
Where
1 siteFrance
Study dates
27 Jun 2025to Jun 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Physicians and medical residents volunteering to participate in the PREVMED study. Participants are recruited through an online REDCap® questionnaire distributed through various channels, including social networks, mailing lists, and flyers containing a link to the questionnaire.

Who may be able to join

  • Physician or medical resident volunteering to participate in the study.

Who cannot join

  • Person not willing to participate in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Frédéric Dutheil, PU-PH contact

+33473178260

fdutheil@chu-clermontferrand.fr

France1 site, 1 recruiting
  • Clermont-Ferrand University Hospital

    Clermont-Ferrand, 63000

    Frédéric Dutheil, PU-PH, +33473178260, fdutheil@chu-clermontferrand.fr

    Recruiting

Other trials in France

About this study

Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable.

The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these practices.

Read the detailed description

PREVMED is an observational cross-sectional questionnaire survey conducted among physicians and medical residents using an anonymous self-administered online questionnaire hosted on REDCap®.

The primary objective is to describe physicians' preventive practices. The secondary objective is to investigate the influence of sociodemographic, occupational, and lifestyle factors on these practices.

The questionnaire assesses preventive practices toward patients, including assessment, oral advice, written advice or treatment, and referral to dedicated consultations regarding physical activity, diet, tobacco, alcohol, cannabis, and sun exposure. It also investigates practices related to screening and prevention for several cancers, including lung, breast, cervical, prostate, and skin cancer.

Sociodemographic characteristics, lifestyle factors, and occupational characteristics of participating physicians are also collected.

The questionnaire is distributed to physicians and medical residents through an internet link using various channels, including social networks, mailing lists, and flyers. Data are collected anonymously.

Being tested
PREVMED questionnaire
Keywords
Preventive practices, Physicians, Screening practices

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PREVMED questionnaireOther

    Anonymous self-administered online questionnaire assessing physicians' preventive practices toward their patients, as well as sociodemographic, occupational, and lifestyle factors that may influence these practices.

Study groups in NCT07829601
Study groupRoleWhat they receive
Physicians and medical residentsNot described
Receives: Other: PREVMED questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of patients' preventive health behaviors

    Frequency of assessment of patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent assessment.

    Measured: Baseline

  2. Oral preventive advice provided to patients

    Frequency of oral advice provided to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent provision of oral advice.

    Measured: Baseline

  3. Written preventive advice or treatment prescribed to patients

    Frequency of written advice or treatment prescribed to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent prescription of written advice or treatment.

    Measured: Baseline

  4. Referral to dedicated preventive consultations

    Frequency of referral of patients to dedicated consultations for physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent referral.

    Measured: Baseline

  5. Verification of recommended screening and medical examinations

    Frequency with which physicians ensure that patients undergo mammography for organized breast cancer screening, cervical screening, fecal occult blood testing for organized colorectal cancer screening, and regular blood tests. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent verification.

    Measured: Baseline

  6. Lung cancer screening practice

    Frequency of proposing lung cancer screening to asymptomatic patients at risk, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of lung cancer screening.

    Measured: Baseline

  7. Breast palpation practice

    Frequency of proposing breast palpation to patients, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of breast palpation.

    Measured: Baseline

  8. Cervical screening practice

    Frequency of proposing cervical screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of cervical screening.

    Measured: Baseline

  9. Prostate cancer screening practice

    Frequency of proposing prostate cancer screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of prostate cancer screening.

    Measured: Baseline

  10. Recommendation of skin self-examination

    Frequency of advising patients to perform skin self-examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent recommendation of skin self-examination.

    Measured: Baseline

  11. Visual skin examination

    Frequency of performing visual skin examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent visual skin examination.

    Measured: Baseline

  12. Frequency of screening blood tests

    Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.

    Measured: Baseline

Secondary outcomes (34)
  1. Tobacco cessation treatments prescribed

    Types of treatment prescribed for smoking cessation, including varenicline, nicotine patches, nicotine gum, bupropion, cytisine, and electronic cigarettes. Multiple responses are permitted.

    Measured: Baseline

  2. Screening blood tests prescribed

    Types of screening blood tests prescribed, including complete blood count, lipid profile, blood glucose, renal function, viral serology, inflammatory markers, and other tests. Multiple responses are permitted.

    Measured: Baseline

  3. Frequency of screening blood tests

    Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.

    Measured: Baseline

  4. Criteria used for lung cancer screening

    Criteria used to propose lung cancer screening, including smoking, occupational exposure, non-occupational exposure, family history of lung cancer, and other criteria. Multiple responses are permitted.

    Measured: Baseline

  5. Lung cancer screening method

    Methods used for lung cancer screening, including chest radiography, chest computed tomography, pulmonary function testing, and other methods. Multiple responses are permitted.

    Measured: Baseline

  6. Frequency of lung cancer screening

    Reported frequency of lung cancer screening according to the predefined categories of the questionnaire.

    Measured: Baseline

  7. Factors limiting lung cancer screening

    Factors limiting prescription of lung cancer screening, including lack of recommendations, insufficient scientific evidence, insufficient knowledge of the topic, limited access to imaging, lack of patient adherence, and follow-up already provided by another physician. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.

    Measured: Baseline

  8. Criteria used for breast palpation

    Criteria used to propose breast palpation, including systematic examination, age, clinical symptoms, family history of breast cancer, prolonged hormonal exposure, and other risk factors. Multiple responses are permitted.

    Measured: Baseline

  9. Factors limiting breast palpation

    Factors limiting breast palpation, including lack of time, lack of training, fear of being accused of inappropriate touching, lack of recommendations, insufficient scientific evidence, lack of patient adherence, follow-up already provided by another physician, and teaching patients breast self-examination. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.

    Measured: Baseline

  10. Factors limiting cervical screening

    Factors limiting cervical screening, including lack of time, lack of training, fear of being accused of inappropriate touching, and follow-up already provided by another physician. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.

    Measured: Baseline

  11. Criteria used for prostate cancer screening

    Criteria used to propose prostate cancer screening, including systematic screening, age, clinical symptoms, family history of prostate cancer, ethnicity, and other risk factors. Multiple responses are permitted.

    Measured: Baseline

  12. Prostate cancer screening method

    Method used for prostate cancer screening, categorized as digital rectal examination alone, prostate-specific antigen (PSA) testing alone, or digital rectal examination combined with PSA testing.

    Measured: Baseline

  13. Factors limiting prostate cancer screening

    Factors limiting prostate cancer screening, including lack of time, lack of training, fear of being accused of inappropriate touching, lack of recommendations, insufficient scientific evidence, lack of patient adherence, and follow-up already provided by another physician. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.

    Measured: Baseline

  14. Criteria used for visual skin examination

    Criteria used to perform visual skin examination, including systematic examination, light skin phototype, age, clinical symptoms, family history of skin cancer, frequent or excessive sun exposure, numerous nevi, and other risk factors. Multiple responses are permitted.

    Measured: Baseline

  15. Factors limiting skin cancer screening

    Factors limiting skin cancer screening, including lack of time, lack of training, absence of a dermatoscope, fear of being accused of inappropriate examination, lack of recommendations, insufficient scientific evidence, lack of patient adherence, follow-up already provided by another physician, and teaching patients skin self-examination. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.

    Measured: Baseline

  16. Professional status

    Professional status of the participant, categorized as physician or medical resident.

    Measured: Baseline

  17. Medical specialty

    Medical specialty of the participant, categorized as general practice, medical specialty, surgery, or psychiatry. Medical and surgical specialties are further specified according to the predefined categories of the questionnaire.

    Measured: Baseline

  18. Practice area

    Geographical practice area, categorized as rural, urban, or semi-urban.

    Measured: Baseline

  19. Practice setting

    Practice setting of the participant, including private practice, hospital practice, salaried practice, no current practice, retired, or other. Multiple responses are permitted.

    Measured: baseline

  20. Working environment

    Working environment, including working alone, group practice, multidisciplinary health center, Maison Sport Santé, with secretarial support, or without secretarial support. Multiple responses are permitted.

    Measured: Baseline

  21. Supervision of students

    Supervision of students, categorized as yes or no.

    Measured: Baseline

  22. Number of patients per week

    Total number of patients seen per week, categorized as 0, 1-20, 20-50, 50-100, 100-150, or more than 150 patients per week.

    Measured: Baseline

  23. Weekly working time

    Total working time per week, categorized as 0, 1-10, 10-20, 20-30, 30-40, 40-50, or more than 50 hours per week.

    Measured: Baseline

  24. On-call duties

    On-call duties assessed separately for private practice and hospital practice, with each categorized as yes or no.

    Measured: Baseline

  25. Tobacco consumption

    Daily tobacco consumption, categorized as 0, 1-4, 5-9, 10-14, 15-19, or more than 20 cigarettes per day.

    Measured: Baseline

  26. Alcohol consumption

    Weekly alcohol consumption, categorized as 0, 1-4, 5-9, 10-14, 15-19, or more than 20 alcoholic drinks per week.

    Measured: Baseline

  27. Cannabis consumption

    Weekly cannabis consumption, categorized as 0, 1-4, 5-9, 10-14, 15-19, or more than 20 joints per week.

    Measured: Baseline

  28. Daily sitting time

    Total time spent sitting per day, expressed in hours per day and recorded from 0 to 24 hours in 30-minute increments.

    Measured: Baseline

  29. Leisure-time physical activity

    Time spent in leisure-time physical activity, expressed in hours per week and recorded from 0 to 24 hours in 30-minute increments.

    Measured: Baseline

  30. Body mass index

    Body mass index calculated automatically from self-reported height in centimeters and weight in kilograms, expressed in kg/m².

    Measured: Baseline

  31. Age

    Age of the participant, expressed in years.

    Measured: Baseline

  32. Gender

    Gender of the participant, categorized as male or female.

    Measured: Baseline

  33. Family status

    Family status of the participant, categorized as single or in a couple.

    Measured: Baseline

  34. Number of children

    Total number of children reported by the participant.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2026
  2. Study start27 Jun 2025
  3. Primary completionJun 2028 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07829601
Sponsor's protocol ID
2026_DUTHEIL_Prevmed
Acronym
Prevmed
Status last verified
Sep 2026
First submitted
14 Sep 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Preventive Practice, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Frédéric Dutheil, PU-PH (+33473178260, fdutheil@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of patients' preventive health behaviors (time frame: Baseline). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in